NR4A1 and cancer: Estrogen receptor (ER)-positive cancers contain cells that respond to estrogen signaling, progesterone receptor (PR)-positive cancers respond to progesterone signaling, and cancer subtypes that respond to neither estrogen nor progesterone are deemed hormone receptor (HR)-negative.